Alto Neuroscience (ANRO) Assets Average (2024 - 2026)

Alto Neuroscience has reported Assets Average for 3 years, with the latest figure at $230.5 million in Q1 2026.

• Quarterly Assets Average rose 31.9% year-over-year to $230.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $230.5 million (up 31.9% YoY) and the FY2025 annual result came in at $181.1 million, up 37.12% from the prior year.
• Assets Average grew to $230.5 million in Q1 2026 per ANRO's latest filing, from $165.8 million in the prior quarter.
• Over five years, Assets Average peaked at $230.5 million in Q1 2026 and troughed at $148.3 million in Q1 2024.
• A 3-year average of $179.9 million and a median of $174.7 million in 2025 frame the typical range for Assets Average.
• The sharpest annual moves came in 2025 and 2026: Assets Average fell 21.62% in 2025, then soared 31.9% in 2026.
• Over 3 years, Assets Average stood at $184.6 million in 2024, then decreased by 10.15% to $165.8 million in 2025, then soared by 38.97% to $230.5 million in 2026.
• According to Business Quant data, Assets Average over the past three periods registered $230.5 million, $165.8 million, and $152.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.